<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-27950" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Pseudomyxoma Peritonei</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Yu</surname>
            <given-names>Bo</given-names>
          </name>
          <aff>Lincoln Medical Center, Bronx, NY</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Raj</surname>
            <given-names>Moses S.</given-names>
          </name>
          <aff>Temple University school of Medicine</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Bo Yu declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Moses Raj declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>27</day>
          <month>3</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-27950.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Pseudomyxoma peritonei (PMP) is a rare clinical entity characterized by diffuse intra-abdominal gelatinous ascites with mucinous implants on peritoneal surfaces. Proper diagnosis and management of pseudomyxoma peritonei can majorly impact a patient's lifespan and quality of life. This activity outlines the evaluation and management of pseudomyxoma peritonei, and highlights the role of the interprofessional team in improving care for patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the pathophysiology of pseudomyxoma peritonei.</p></list-item><list-item><p>Outline the typical presentation of a patient with pseudomyxoma peritonei.</p></list-item><list-item><p>Summarize the management considerations for patients with pseudomyxoma peritonei.</p></list-item><list-item><p>Explain the importance of improving care coordination amongst interprofessional team members to improve outcomes for patients affected by pseudomyxoma peritonei.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=27950&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=27950">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-27950.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Pseudomyxoma peritonei (PMP) is a rare clinical entity, characterized by diffuse intra-abdominal gelatinous ascites, the so-called &#x0201c;jelly belly,&#x0201d; with mucinous implants on peritoneal surfaces.<xref ref-type="bibr" rid="article-27950.r1">[1]</xref>&#x000a0;Werth first introduced the term pseudomyxoma peritonei in 1884. It was initially believed to arise from a perforated cystadenoma of the appendix. However, currently, it has been more widely used to describe peritoneal dissemination of mucus-producing neoplasm most frequently from the appendix, but also small and large bowel, stomach, pancreas, lung, breast, gallbladder, fallopian tubes, and ovaries.<xref ref-type="bibr" rid="article-27950.r2">[2]</xref><xref ref-type="bibr" rid="article-27950.r3">[3]</xref>&#x000a0;Due to its indolent behavior, pseudomyxoma peritonei is often discovered incidentally with a relatively advanced stage during laparoscopy, laparotomy or imaging studies for other medical concerns. Pseudomyxoma peritonei merits consideration as a &#x02018;borderline malignancy&#x02019; with changing prognosis based on the site of origin.<xref ref-type="bibr" rid="article-27950.r4">[4]</xref></p>
      </sec>
      <sec id="article-27950.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Patients with familial adenomatous polyposis (FAP) demonstrate an increased risk of developing mucinous adenocarcinoma of the appendix. KRAS mutation has also been present in 70 % of appendiceal adenomas.<xref ref-type="bibr" rid="article-27950.r5">[5]</xref></p>
      </sec>
      <sec id="article-27950.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The estimated incidence of pseudomyxoma peritonei is approximately 1 to 4 out of a million annually.<xref ref-type="bibr" rid="article-27950.r3">[3]</xref>&#x000a0;The primary site is identified predominantly as mucinous appendiceal adenocarcinoma.<xref ref-type="bibr" rid="article-27950.r6">[6]</xref>&#x000a0;Patients have an average age of 53 years at the time of diagnosis. Females are affected more frequently than males.<xref ref-type="bibr" rid="article-27950.r7">[7]</xref></p>
      </sec>
      <sec id="article-27950.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>There are several steps involved in the pathogenesis of pseudomyxoma peritonei. Initially, tumor cells originating from the mucinous epithelium of the appendix continuously produce mucus into the appendiceal lumen and form a mucocele, which eventually ruptures. Free-floating mucinous epithelial tumor cells then implant in various parts of peritoneal cavity following the intraperitoneal fluid current and gravity, thanks to their absence of adhesive properties. It is termed as the so-called &#x02018;redistribution phenomenon.&#x02019;<xref ref-type="bibr" rid="article-27950.r8">[8]</xref>&#x000a0;The intraperitoneal fluid is most frequently reabsorbed through the right paracolic gutter toward the right hemidiaphragm and the greater and lesser omentum, thus becoming the major sites of tumor deposits when cells get trapped in small lymphatic systems. Gravity is another important redistribution mechanism, which facilitates the accumulation of tumor cells in the pelvis, such as the rectovesical pouch or the pouch of Douglas.</p>
        <p>Mobile organs such as the small bowel and its mesentery are usually less likely to be involved compared to more fixed parts such as antrum, duodenojejunal flexure, ligament of Treitz, ileocecal and rectosigmoid region, early in the disease process. But in the end-stage disease, the entire peritoneal cavity could be engulfed.<xref ref-type="bibr" rid="article-27950.r9">[9]</xref>&#x000a0;The implanted tumor cells continue to proliferate and produce a large amount of mucus and eventually form mucinous ascites over months or even years. The excessive tumor burden and subsequent high intra-abdominal pressure can further limit bowel movement and even result in small bowel obstruction that requires surgical resection. The extra-peritoneal invasion has been reported mainly in the pleural cavity.<xref ref-type="bibr" rid="article-27950.r10">[10]</xref>&#x000a0;Lymphatic or hematogenic metastasis are rare occurrences.<xref ref-type="bibr" rid="article-27950.r3">[3]</xref><xref ref-type="bibr" rid="article-27950.r7">[7]</xref><xref ref-type="bibr" rid="article-27950.r11">[11]</xref><xref ref-type="bibr" rid="article-27950.r12">[12]</xref></p>
      </sec>
      <sec id="article-27950.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>
<italic toggle="yes">Macroscopic Findings: </italic>
</p>
        <p>Macroscopic examination often reveals abundant gelatinous pelvic or abdominal mucin or mucinous ascites accompanied by cystic epithelial implants on peritoneal surfaces. These lesions vary in size from a few mm to a few centimeters. A large &#x02018;omental cake&#x02019; is also frequently found.<xref ref-type="bibr" rid="article-27950.r13">[13]</xref></p>
        <p>
<italic toggle="yes">Histopathology:</italic>
</p>
        <p>Multiple histological grading systems have been proposed for pseudomyxoma peritonei. Ronnett et al. first divided pseudomyxoma peritonei into two groups: disseminated peritoneal adenomucinosis (DPAM) and peritoneal mucinous carcinomatosis (PMCA).<xref ref-type="bibr" rid="article-27950.r14">[14]</xref> DPAM is characterized by abundant mucus containing scanty mucinous epithelial cells with minimal cytological atypia and mitotic activity, while PMCA is featured by more abundant mucinous epithelial cells with high-grade cytological atypia and mitotic activity. In 2010, the World Health Organization (WHO) further refined the grading system.<xref ref-type="bibr" rid="article-27950.r15">[15]</xref><xref ref-type="bibr" rid="article-27950.r16">[16]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Acellular mucin: Mucin within the peritoneal cavity without neoplastic epithelial cells.</p>
          </list-item>
          <list-item>
            <p>Low-grade mucinous carcinoma peritonei (synonymous with DPAM) presents as mucin pools with low cellularity (less than 10%), bland cytology and non-stratified cuboidal epithelium. Tumor cells are arranged in strips or gland-like structures. Infiltrative growth is not present.</p>
          </list-item>
          <list-item>
            <p>High-grade mucinous carcinoma peritonei (synonymous with PMCA): Mucin pools with high cellularity, moderate/severe cytological atypia, numerous mitoses, and cribriform growth pattern. Destructive infiltrative invasion of underlying organs is often present.</p>
          </list-item>
          <list-item>
            <p>High-grade mucinous carcinoma peritonei with signet ring cells: Any lesion with a component of signet ring cells, classified separately because of their worse prognosis.<xref ref-type="bibr" rid="article-27950.r17">[17]</xref><xref ref-type="bibr" rid="article-27950.r18">[18]</xref></p>
          </list-item>
        </list>
        <p>
<italic toggle="yes">Immunohistochemistry:</italic>
</p>
        <p>Researchers have suggested MUC 2 over-expression as a molecular marker for PMP of intestinal origin.<xref ref-type="bibr" rid="article-27950.r19">[19]</xref>&#x000a0;Appendiceal tumors also express CK20, CEA, and CDX2, and are usually negative for CK7 and CA 125.<xref ref-type="bibr" rid="article-27950.r15">[15]</xref> There are also reports of loss of protein expression of the repair genes MLH1 and PMS2.<xref ref-type="bibr" rid="article-27950.r20">[20]</xref></p>
      </sec>
      <sec id="article-27950.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>At the initial stage, pseudomyxoma peritonei is often asymptomatic or presents with non-specific signs and symptoms sometimes misdiagnosed as irritable bowel syndrome. As the disease progresses, patients may present with appendicitis-like symptoms, increased abdominal girth, the presence of pelvic masses or new-onset hernia. More advanced disease may result in abdominal distension, ascites, bowel obstruction, and nutritional compromise. Reports also exist of superinfected pseudomyxoma peritonei and subsequent sepsis.<xref ref-type="bibr" rid="article-27950.r21">[21]</xref></p>
        <p>Physical examination may reveal a distended abdomen with a palpable omental cake. A rectal exam may reveal deposits in the pouch of Douglas or the rectovesical pouch. Ovarian masses may be palpable in females.</p>
      </sec>
      <sec id="article-27950.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>
<italic toggle="yes">Imaging studies:</italic>
</p>
        <p>CT scan with contrast of the chest, abdomen, and pelvis is currently the imaging modality of choice for the diagnosis of pseudomyxoma peritonei. Typical CT appearance is &#x02018;scalloping&#x02019; of the surface of the liver and spleen caused by loculated accumulations of mucin, which distinguishes mucin from fluid ascites. The mucinous material is similar in density to water. There are also islands of higher attenuation due to scattered solid elements and calcification within mucinous material. However, the primary appendiceal lesion might be absent or hard to identify on imaging. Compared to CT, gadolinium-enhanced MRI is more sensitive in localizing the tumor, and in assessing the small bowel as well as the hepatoduodenal ligament. PET/CT scan might be helpful in more aggressive variants by detecting extra-abdominal disease.<xref ref-type="bibr" rid="article-27950.r3">[3]</xref></p>
        <p>
<italic toggle="yes">Circulating tumor markers:</italic>
</p>
        <p>Tumor markers are found to have prognostic value and are useful for follow up of patients after treatment. CEA and CA 19.9 are found to have a high level in PMP with an appendiceal origin. CA 125 is also found to be high but with ovarian involvement.<xref ref-type="bibr" rid="article-27950.r15">[15]</xref></p>
        <p>
<italic toggle="yes">Histopathology: </italic>
</p>
        <p>The final diagnosis relies on histopathological examination of the biopsy and surgical specimen through laparoscopy or laparotomy, especially when the clinical and radiological manifestations are not specific. Percutaneous image-guided biopsies are of limited value since the resultant material may be acellular mucin.<xref ref-type="bibr" rid="article-27950.r22">[22]</xref></p>
      </sec>
      <sec id="article-27950.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Traditional periodic surgical debulking has been less favored because of inevitable disease recurrence and a higher risk of repeated surgeries.<xref ref-type="bibr" rid="article-27950.r23">[23]</xref>&#x000a0;Current recommended standard treatment for PMP consists of complete cytoreduction surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). The goal of CRS is to remove all visible tumors. Resection is considered complete if no masses larger than 2.5 mm are left.<xref ref-type="bibr" rid="article-27950.r24">[24]</xref>&#x000a0;HIPEC aims at eradicating any macroscopic or microscopic tumor residues. The most commonly used chemotherapeutic agent is mitomycin C (MMC), and the rationale for heating is to increase drug penetration. A baseline CT scan, as well as tumor markers, are recommended to be completed 3 months postoperatively and then every 6 months to monitor recurrence. Elective second look surgery when recurrence is considered for selected patients.<xref ref-type="bibr" rid="article-27950.r22">[22]</xref><xref ref-type="bibr" rid="article-27950.r25">[25]</xref>&#x000a0;However, since CRS/HIPEC is an aggressive treatment, medical comorbidities should be carefully assessed preoperatively. And patients with high-grade lesions or signet ring cell components with an ECOG (Eastern Co-operative Oncology Group) performance score of 2 to 3 have significantly poorer overall survival after the surgery. Those patients may benefit from a major palliative resection to improve quality of life.<xref ref-type="bibr" rid="article-27950.r26">[26]</xref>&#x000a0;Postoperative systemic chemotherapy has been shown to benefit patients with high-grade neoplasm after CRS/HIPEC, but not those with low-grade neoplasm. However, there&#x02019;s currently no widely accepted standardized plan. Preoperative systemic chemotherapy is generally not helpful.<xref ref-type="bibr" rid="article-27950.r27">[27]</xref></p>
      </sec>
      <sec id="article-27950.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>Ascites from another origin (cirrhosis, CHF)</p>
          </list-item>
          <list-item>
            <p>Ruptured mucinous cystadenomas of appendix or ovary</p>
          </list-item>
          <list-item>
            <p>Endometriosis with myxoid change</p>
          </list-item>
          <list-item>
            <p>Ruptured viscus with mucus extravasation</p>
          </list-item>
          <list-item>
            <p>Soft tissue neoplasms with myxoid changes</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-27950.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Prognosis of pseudomyxoma peritonei correlates closely to histopathological classification. The ten-year survival rate of patients with low-grade tumors/DPAM is 63% compared to 40.1% in patients with high-grade tumors/PMCA and 0% in patients with high-grade tumors with signet ring cells following the treatment of CRS/HIPEC in one recent study. <xref ref-type="bibr" rid="article-27950.r28">[28]</xref>&#x000a0;However data varies between different studies. <xref ref-type="bibr" rid="article-27950.r29">[29]</xref><xref ref-type="bibr" rid="article-27950.r30">[30]</xref><xref ref-type="bibr" rid="article-27950.r31">[31]</xref><xref ref-type="bibr" rid="article-27950.r32">[32]</xref>&#x000a0;Above all, patients who are undergoing CRS/HIPEC present with a better long-term outcome than those undergoing debulking surgery.<xref ref-type="bibr" rid="article-27950.r33">[33]</xref></p>
      </sec>
      <sec id="article-27950.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Major complications after CRS/HIPEC include thromboembolism, anastomotic leak, bowel perforation, fistula formation, abscess, and wound dehiscence. There is also a high risk for neutropenia, sepsis, pleural effusion, and respiratory insufficiency.<xref ref-type="bibr" rid="article-27950.r24">[24]</xref><xref ref-type="bibr" rid="article-27950.r34">[34]</xref></p>
      </sec>
      <sec id="article-27950.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patient with a newly diagnosed pseudomyxoma peritonei is recommended to undergo CRS/HIPEC if medically fit with the goal of achieving complete cytoreduction.&#x000a0; Even though the long-term outcomes after treatment are impressive for patients with low-grade histology, there&#x02019;s still a significant recurrence of the disease. Regular follow-up is essential to monitor disease progression.</p>
      </sec>
      <sec id="article-27950.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Most cases of pseudomyxoma peritonei are discovered in an advanced stage due to its indolent behavior. Pathological diagnosis is crucial to determine the treatment plan. When suspicious lesions are encountered incidentally during laparoscopy or laparotomy, the best strategy is to take generous biopsies, remove appendix if accessible, and only proceed with further treatment after pathological confirmation of the diagnosis and clinical assessment of the patient. During follow-up, the primary care provider, nurse practitioner or internist should be aware of recurrence and consider imaging studies and referral to the oncologist. Pseudomyxoma peritonei treatment is best in an interprofessional team approach including specialists, oncology trained specialty nursing, and when necessary, pharmacists, collaborating for optimal patient care and outcomes. [Level V]</p>
      </sec>
      <sec id="article-27950.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=27950&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=27950">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/gut-health/pseudomyxoma-peritonei/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=27950">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/27950/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=27950">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-27950.s16">
        <fig id="article-27950.image.f1" position="float" orientation="portrait">
          <caption>
            <p>CT scan of pseudomyxoma peritonei showing scalloping of liver and spleen contributed by Katharine E Bevan, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pseudomyxoma__peritonei__scalloping" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-27950.s17">
        <title>References</title>
        <ref id="article-27950.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moran</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Cecil</surname>
                <given-names>TD</given-names>
              </name>
            </person-group>
            <article-title>The etiology, clinical presentation, and management of pseudomyxoma peritonei.</article-title>
            <source>Surg Oncol Clin N Am</source>
            <year>2003</year>
            <month>Jul</month>
            <volume>12</volume>
            <issue>3</issue>
            <fpage>585</fpage>
            <page-range>585-603</page-range>
            <pub-id pub-id-type="pmid">14567019</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27950.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Darr</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Renno</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Alkully</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Tiwari</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zeb</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Purdy</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Nawras</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis of Pseudomyxoma peritonei via endoscopic ultrasound guided fine needle aspiration: a case report and review of literature.</article-title>
            <source>Scand J Gastroenterol</source>
            <year>2017</year>
            <month>May</month>
            <volume>52</volume>
            <issue>5</issue>
            <fpage>609</fpage>
            <page-range>609-612</page-range>
            <pub-id pub-id-type="pmid">28155576</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27950.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mittal</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Chandramohan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Moran</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Pseudomyxoma peritonei: natural history and treatment.</article-title>
            <source>Int J Hyperthermia</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>33</volume>
            <issue>5</issue>
            <fpage>511</fpage>
            <page-range>511-519</page-range>
            <pub-id pub-id-type="pmid">28540829</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27950.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baratti</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kusamura</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Milione</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pietrantonio</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Caporale</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Guaglio</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Deraco</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Pseudomyxoma Peritonei of Extra-Appendiceal Origin: A Comparative Study.</article-title>
            <source>Ann Surg Oncol</source>
            <year>2016</year>
            <month>Dec</month>
            <volume>23</volume>
            <issue>13</issue>
            <fpage>4222</fpage>
            <page-range>4222-4230</page-range>
            <pub-id pub-id-type="pmid">27352203</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27950.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shih</surname>
                <given-names>IM</given-names>
              </name>
              <name>
                <surname>Yan</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Speyrer</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Shmookler</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Sugarbaker</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>Ronnett</surname>
                <given-names>BM</given-names>
              </name>
            </person-group>
            <article-title>Molecular genetic analysis of appendiceal mucinous adenomas in identical twins, including one with pseudomyxoma peritonei.</article-title>
            <source>Am J Surg Pathol</source>
            <year>2001</year>
            <month>Aug</month>
            <volume>25</volume>
            <issue>8</issue>
            <fpage>1095</fpage>
            <page-range>1095-9</page-range>
            <pub-id pub-id-type="pmid">11474297</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27950.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Smeenk</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>van Velthuysen</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Verwaal</surname>
                <given-names>VJ</given-names>
              </name>
              <name>
                <surname>Zoetmulder</surname>
                <given-names>FA</given-names>
              </name>
            </person-group>
            <article-title>Appendiceal neoplasms and pseudomyxoma peritonei: a population based study.</article-title>
            <source>Eur J Surg Oncol</source>
            <year>2008</year>
            <month>Feb</month>
            <volume>34</volume>
            <issue>2</issue>
            <fpage>196</fpage>
            <page-range>196-201</page-range>
            <pub-id pub-id-type="pmid">17524597</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27950.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Garc&#x000ed;a</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Flores</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Ruiz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gonz&#x000e1;lez</surname>
                <given-names>FL</given-names>
              </name>
              <name>
                <surname>Rodr&#x000ed;guez</surname>
                <given-names>&#x000c1;M</given-names>
              </name>
            </person-group>
            <article-title>Pseudomyxoma Peritonei: Case Report and Literature Review.</article-title>
            <source>J Gastrointest Cancer</source>
            <year>2019</year>
            <month>Dec</month>
            <volume>50</volume>
            <issue>4</issue>
            <fpage>1037</fpage>
            <page-range>1037-1042</page-range>
            <pub-id pub-id-type="pmid">30618002</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27950.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sugarbaker</surname>
                <given-names>PH</given-names>
              </name>
            </person-group>
            <article-title>Pseudomyxoma peritonei. A cancer whose biology is characterized by a redistribution phenomenon.</article-title>
            <source>Ann Surg</source>
            <year>1994</year>
            <month>Feb</month>
            <volume>219</volume>
            <issue>2</issue>
            <fpage>109</fpage>
            <page-range>109-11</page-range>
            <pub-id pub-id-type="pmid">8129480</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27950.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sulkin</surname>
                <given-names>TV</given-names>
              </name>
              <name>
                <surname>O'Neill</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Amin</surname>
                <given-names>AI</given-names>
              </name>
              <name>
                <surname>Moran</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>CT in pseudomyxoma peritonei: a review of 17 cases.</article-title>
            <source>Clin Radiol</source>
            <year>2002</year>
            <month>Jul</month>
            <volume>57</volume>
            <issue>7</issue>
            <fpage>608</fpage>
            <page-range>608-13</page-range>
            <pub-id pub-id-type="pmid">12096860</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27950.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pestieau</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Esquivel</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sugarbaker</surname>
                <given-names>PH</given-names>
              </name>
            </person-group>
            <article-title>Pleural extension of mucinous tumor in patients with pseudomyxoma peritonei syndrome.</article-title>
            <source>Ann Surg Oncol</source>
            <year>2000</year>
            <month>Apr</month>
            <volume>7</volume>
            <issue>3</issue>
            <fpage>199</fpage>
            <page-range>199-203</page-range>
            <pub-id pub-id-type="pmid">10791850</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27950.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Smeenk</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Bruin</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>van Velthuysen</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Verwaal</surname>
                <given-names>VJ</given-names>
              </name>
            </person-group>
            <article-title>Pseudomyxoma peritonei.</article-title>
            <source>Curr Probl Surg</source>
            <year>2008</year>
            <month>Aug</month>
            <volume>45</volume>
            <issue>8</issue>
            <fpage>527</fpage>
            <page-range>527-75</page-range>
            <pub-id pub-id-type="pmid">18590843</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27950.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rizvi</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Syed</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Shergill</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Approach to pseudomyxoma peritonei.</article-title>
            <source>World J Gastrointest Surg</source>
            <year>2018</year>
            <month>Aug</month>
            <day>27</day>
            <volume>10</volume>
            <issue>5</issue>
            <fpage>49</fpage>
            <page-range>49-56</page-range>
            <pub-id pub-id-type="pmid">30190782</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27950.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sugarbaker</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>Ronnett</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Archer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Averbach</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Bland</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Dalton</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Ettinghausen</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Jacquet</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Jelinek</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Koslowe</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kurman</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Shmookler</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Stephens</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Steves</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Stuart</surname>
                <given-names>OA</given-names>
              </name>
              <name>
                <surname>White</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zahn</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Zoetmulder</surname>
                <given-names>FA</given-names>
              </name>
            </person-group>
            <article-title>Pseudomyxoma peritonei syndrome.</article-title>
            <source>Adv Surg</source>
            <year>1996</year>
            <volume>30</volume>
            <fpage>233</fpage>
            <page-range>233-80</page-range>
            <pub-id pub-id-type="pmid">8960339</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27950.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ronnett</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Zahn</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Kurman</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Kass</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Sugarbaker</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>Shmookler</surname>
                <given-names>BM</given-names>
              </name>
            </person-group>
            <article-title>Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei".</article-title>
            <source>Am J Surg Pathol</source>
            <year>1995</year>
            <month>Dec</month>
            <volume>19</volume>
            <issue>12</issue>
            <fpage>1390</fpage>
            <page-range>1390-408</page-range>
            <pub-id pub-id-type="pmid">7503361</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27950.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ramaswamy</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Pathology of Mucinous Appendiceal Tumors and Pseudomyxoma Peritonei.</article-title>
            <source>Indian J Surg Oncol</source>
            <year>2016</year>
            <month>Jun</month>
            <volume>7</volume>
            <issue>2</issue>
            <fpage>258</fpage>
            <page-range>258-67</page-range>
            <pub-id pub-id-type="pmid">27065718</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27950.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Carr</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Cecil</surname>
                <given-names>TD</given-names>
              </name>
              <name>
                <surname>Mohamed</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Sobin</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Sugarbaker</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>Gonz&#x000e1;lez-Moreno</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Taflampas</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Chapman</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Moran</surname>
                <given-names>BJ</given-names>
              </name>
              <collab>Peritoneal Surface Oncology Group International</collab>
            </person-group>
            <article-title>A Consensus for Classification and Pathologic Reporting of Pseudomyxoma Peritonei and Associated Appendiceal Neoplasia: The Results of the Peritoneal Surface Oncology Group International (PSOGI) Modified Delphi Process.</article-title>
            <source>Am J Surg Pathol</source>
            <year>2016</year>
            <month>Jan</month>
            <volume>40</volume>
            <issue>1</issue>
            <fpage>14</fpage>
            <page-range>14-26</page-range>
            <pub-id pub-id-type="pmid">26492181</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27950.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shetty</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Natarajan</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Govindarajan</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Loggie</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Proposed classification of pseudomyxoma peritonei: influence of signet ring cells on survival.</article-title>
            <source>Am Surg</source>
            <year>2013</year>
            <month>Nov</month>
            <volume>79</volume>
            <issue>11</issue>
            <fpage>1171</fpage>
            <page-range>1171-6</page-range>
            <pub-id pub-id-type="pmid">24165252</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27950.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Carr</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Bibeau</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Bradley</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Dartigues</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Feakins</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Geisinger</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Gui</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Isaac</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Milione</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Misdraji</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pai</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Rodriguez-Justo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sobin</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>van Velthuysen</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Yantiss</surname>
                <given-names>RK</given-names>
              </name>
            </person-group>
            <article-title>The histopathological classification, diagnosis and differential diagnosis of mucinous appendiceal neoplasms, appendiceal adenocarcinomas and pseudomyxoma peritonei.</article-title>
            <source>Histopathology</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>71</volume>
            <issue>6</issue>
            <fpage>847</fpage>
            <page-range>847-858</page-range>
            <pub-id pub-id-type="pmid">28746986</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27950.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ferreira</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Carvalho</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Soares</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Siqueira</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Carvalho</surname>
                <given-names>FM</given-names>
              </name>
            </person-group>
            <article-title>Mucinous ovarian tumors associated with pseudomyxoma peritonei of adenomucinosis type: immunohistochemical evidence that they are secondary tumors.</article-title>
            <source>Int J Gynecol Cancer</source>
            <year>2008</year>
            <season>Jan-Feb</season>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>59</fpage>
            <page-range>59-65</page-range>
            <pub-id pub-id-type="pmid">17511804</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27950.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fernandes</surname>
                <given-names>ACO</given-names>
              </name>
              <name>
                <surname>Rocha</surname>
                <given-names>GRMD</given-names>
              </name>
              <name>
                <surname>Oliveira</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Guimar&#x000e3;es</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Carvalho</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Chojniak</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Pseudomyxoma peritonei in a pediatric patient: A case report and literature review.</article-title>
            <source>Rev Assoc Med Bras (1992)</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>64</volume>
            <issue>2</issue>
            <fpage>195</fpage>
            <page-range>195-199</page-range>
            <pub-id pub-id-type="pmid">29641675</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27950.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sullivan</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Bolton</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Sarpel</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Magge</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>A unique presentation of superinfected pseudomyxoma peritonei secondary to a low-grade appendiceal mucinous neoplasm.</article-title>
            <source>World J Surg Oncol</source>
            <year>2019</year>
            <month>Feb</month>
            <day>18</day>
            <volume>17</volume>
            <issue>1</issue>
            <fpage>34</fpage>
            <pub-id pub-id-type="pmid">30777068</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27950.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bevan</surname>
                <given-names>KE</given-names>
              </name>
              <name>
                <surname>Mohamed</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Moran</surname>
                <given-names>BJ</given-names>
              </name>
            </person-group>
            <article-title>Pseudomyxoma peritonei.</article-title>
            <source>World J Gastrointest Oncol</source>
            <year>2010</year>
            <month>Jan</month>
            <day>15</day>
            <volume>2</volume>
            <issue>1</issue>
            <fpage>44</fpage>
            <page-range>44-50</page-range>
            <pub-id pub-id-type="pmid">21160816</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27950.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hinson</surname>
                <given-names>FL</given-names>
              </name>
              <name>
                <surname>Ambrose</surname>
                <given-names>NS</given-names>
              </name>
            </person-group>
            <article-title>Pseudomyxoma peritonei.</article-title>
            <source>Br J Surg</source>
            <year>1998</year>
            <month>Oct</month>
            <volume>85</volume>
            <issue>10</issue>
            <fpage>1332</fpage>
            <page-range>1332-9</page-range>
            <pub-id pub-id-type="pmid">9782010</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27950.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chua</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Moran</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Sugarbaker</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>Levine</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Glehen</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Gilly</surname>
                <given-names>FN</given-names>
              </name>
              <name>
                <surname>Baratti</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Deraco</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Elias</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Sardi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Liauw</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Yan</surname>
                <given-names>TD</given-names>
              </name>
              <name>
                <surname>Barrios</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>G&#x000f3;mez Portilla</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>de Hingh</surname>
                <given-names>IH</given-names>
              </name>
              <name>
                <surname>Ceelen</surname>
                <given-names>WP</given-names>
              </name>
              <name>
                <surname>Pelz</surname>
                <given-names>JO</given-names>
              </name>
              <name>
                <surname>Piso</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gonz&#x000e1;lez-Moreno</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Van Der Speeten</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Morris</surname>
                <given-names>DL</given-names>
              </name>
            </person-group>
            <article-title>Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.</article-title>
            <source>J Clin Oncol</source>
            <year>2012</year>
            <month>Jul</month>
            <day>10</day>
            <volume>30</volume>
            <issue>20</issue>
            <fpage>2449</fpage>
            <page-range>2449-56</page-range>
            <pub-id pub-id-type="pmid">22614976</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27950.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Smeenk</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Verwaal</surname>
                <given-names>VJ</given-names>
              </name>
              <name>
                <surname>Antonini</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Zoetmulder</surname>
                <given-names>FA</given-names>
              </name>
            </person-group>
            <article-title>Progression of pseudomyxoma peritonei after combined modality treatment: management and outcome.</article-title>
            <source>Ann Surg Oncol</source>
            <year>2007</year>
            <month>Feb</month>
            <volume>14</volume>
            <issue>2</issue>
            <fpage>493</fpage>
            <page-range>493-9</page-range>
            <pub-id pub-id-type="pmid">17103067</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27950.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stewart</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Shen</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Levine</surname>
                <given-names>EA</given-names>
              </name>
            </person-group>
            <article-title>Intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: current status and future directions.</article-title>
            <source>Ann Surg Oncol</source>
            <year>2005</year>
            <month>Oct</month>
            <volume>12</volume>
            <issue>10</issue>
            <fpage>765</fpage>
            <page-range>765-77</page-range>
            <pub-id pub-id-type="pmid">16132375</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27950.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Blackham</surname>
                <given-names>AU</given-names>
              </name>
              <name>
                <surname>Swett</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Eng</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Sirintrapun</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bergman</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Geisinger</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Votanopoulos</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Stewart</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Shen</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Levine</surname>
                <given-names>EA</given-names>
              </name>
            </person-group>
            <article-title>Perioperative systemic chemotherapy for appendiceal mucinous carcinoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.</article-title>
            <source>J Surg Oncol</source>
            <year>2014</year>
            <month>Jun</month>
            <volume>109</volume>
            <issue>7</issue>
            <fpage>740</fpage>
            <page-range>740-5</page-range>
            <pub-id pub-id-type="pmid">24375188</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27950.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Baratti</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kusamura</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Milione</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bruno</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Guaglio</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Deraco</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Validation of the Recent PSOGI Pathological Classification of Pseudomyxoma Peritonei in a Single-Center Series of 265 Patients Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.</article-title>
            <source>Ann Surg Oncol</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>25</volume>
            <issue>2</issue>
            <fpage>404</fpage>
            <page-range>404-413</page-range>
            <pub-id pub-id-type="pmid">29159742</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27950.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pallas</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Karamveri</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kyziridis</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Hristakis</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kyriakopoulos</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Kalakonas</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Vaikos</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Tentes</surname>
                <given-names>AK</given-names>
              </name>
            </person-group>
            <article-title>Cytoreductive surgery and hyperthermic intraperitenoal chemotherapy (HIPEC) for colorectal and appendiceal carcinomas with peritoneal carcinomatosis.</article-title>
            <source>J BUON</source>
            <year>2017</year>
            <season>Nov-Dec</season>
            <volume>22</volume>
            <issue>6</issue>
            <fpage>1547</fpage>
            <page-range>1547-1553</page-range>
            <pub-id pub-id-type="pmid">29332351</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27950.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McQuellon</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Russell</surname>
                <given-names>GB</given-names>
              </name>
              <name>
                <surname>Shen</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Stewart</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Saunders</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Levine</surname>
                <given-names>EA</given-names>
              </name>
            </person-group>
            <article-title>Survival and health outcomes after cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of appendiceal origin.</article-title>
            <source>Ann Surg Oncol</source>
            <year>2008</year>
            <month>Jan</month>
            <volume>15</volume>
            <issue>1</issue>
            <fpage>125</fpage>
            <page-range>125-33</page-range>
            <pub-id pub-id-type="pmid">18030535</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27950.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Moran</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Cecil</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Chandrakumaran</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Arnold</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mohamed</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Venkatasubramaniam</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>The results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in 1200 patients with peritoneal malignancy.</article-title>
            <source>Colorectal Dis</source>
            <year>2015</year>
            <month>Sep</month>
            <volume>17</volume>
            <issue>9</issue>
            <fpage>772</fpage>
            <page-range>772-8</page-range>
            <pub-id pub-id-type="pmid">25880479</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27950.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chua</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Yan</surname>
                <given-names>TD</given-names>
              </name>
              <name>
                <surname>Saxena</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Morris</surname>
                <given-names>DL</given-names>
              </name>
            </person-group>
            <article-title>Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure?: a systematic review of morbidity and mortality.</article-title>
            <source>Ann Surg</source>
            <year>2009</year>
            <month>Jun</month>
            <volume>249</volume>
            <issue>6</issue>
            <fpage>900</fpage>
            <page-range>900-7</page-range>
            <pub-id pub-id-type="pmid">19474692</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27950.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>J&#x000e4;rvinen</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ristim&#x000e4;ki</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kantonen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Aronen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Huuhtanen</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>J&#x000e4;rvinen</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Lepist&#x000f6;</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Comparison of serial debulking and cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei of appendiceal origin.</article-title>
            <source>Int J Colorectal Dis</source>
            <year>2014</year>
            <month>Aug</month>
            <volume>29</volume>
            <issue>8</issue>
            <fpage>999</fpage>
            <page-range>999-1007</page-range>
            <pub-id pub-id-type="pmid">24965858</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27950.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sugarbaker</surname>
                <given-names>PH</given-names>
              </name>
              <name>
                <surname>Ryan</surname>
                <given-names>DP</given-names>
              </name>
            </person-group>
            <article-title>Cytoreductive surgery plus hyperthermic perioperative chemotherapy to treat peritoneal metastases from colorectal cancer: standard of care or an experimental approach?</article-title>
            <source>Lancet Oncol</source>
            <year>2012</year>
            <month>Aug</month>
            <volume>13</volume>
            <issue>8</issue>
            <fpage>e362</fpage>
            <page-range>e362-9</page-range>
            <pub-id pub-id-type="pmid">22846841</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
